The Lyme disease vaccine takes its toll.

Vector borne and zoonotic diseases (Larchmont, N.Y.)

Volumn 2, Issue 4, 2002, Pages 217-222

  Thomas, Venetta ^a   Fikrig, Erol ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; BACTERIUM ANTIBODY; CELL SURFACE RECEPTOR; LIPOPROTEIN; LYME DISEASE VACCINE; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN; OUTER SURFACE PROTEIN A; TLR2 PROTEIN, HUMAN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2;

ANIMAL; ARTICLE; BLOOD; BORRELIA BURGDORFERI; CHEMISTRY; GENETICS; HUMAN; IMMUNOLOGY; LYME DISEASE; MICROBIOLOGY; MOUSE; MOUSE MUTANT;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BORRELIA BURGDORFERI; HUMANS; LIPOPROTEINS; LYME DISEASE; LYME DISEASE VACCINES; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTORS;

EID: 0642371140     PISSN: 15303667     EISSN: None     Source Type: Journal    
DOI: 10.1089/153036602321653798     Document Type: Article

References (0)